GlassScriptPhysician profile
Molly Schreiber
NPI 1114492964
$906.70
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $730 · 2022: $159 · 2023: $18.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $164.33 | 2021-2022 | |
| Novo Nordisk INC | $113.12 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $105.67 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $85.73 | 2021 | |
| Paratek Pharmaceuticals, INC. | $73.20 | 2021 | |
| Lilly USA, LLC | $39.88 | 2021 | |
| Esperion Therapeutics, INC. | $39.28 | 2021 | |
| Alexion Pharmaceuticals, INC. | $36.00 | 2021 | |
| Eisai INC. | $32.15 | 2021 | |
| Daiichi Sankyo INC. | $31.89 | 2021 | |
| Janssen Pharmaceuticals, INC | $30.24 | 2021 | |
| Merck Sharp & Dohme LLC | $23.14 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $21.04 | 2021 | |
| Hologic Sales and Service, LLC | $19.81 | 2022 | |
| Boston Scientific Corporation | $18.07 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.66 | 2022 | |
| Neurocrine Biosciences, INC. | $16.61 | 2021 | |
| Optinose US, INC. | $15.00 | 2021 | |
| Ironshore Pharmaceuticals INC. | $12.93 | 2021 | |
| Nestle Healthcare Nutrition INC. | $11.95 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Schreiber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.